Cobenfy (xanomeline-trospium chloride) was approved for the treatment of adults with schizophrenia in 2024. Cobenfy is the first medicine approved for the treatment of schizophrenia that works ...
Caplyta (lumateperone) is a prescription drug used to treat schizophrenia in adults. It does not come as a generic drug. Caplyta comes as an oral capsule. The active ingredient in Caplyta is ...
The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...
Xanomeline/trospium chloride (Cobenfy) is a new class of medication that can help reduce symptoms and complications associated with schizophrenia. It may be a promising treatment for people who do not ...
It may be time to change schizophrenia treatments if symptoms like hallucinations or social withdrawal persist, side effects affect quality of life, or you experience functional decline or increased ...
Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the ...
An outdated, catch-all diagnosis when symptoms are difficult to classify Medically reviewed by Michael MacIntyre, MD Undifferentiated schizophrenia is an outdated term for a type of schizophrenia with ...